CN213790075U - Continuous purification device for abamectin - Google Patents

Continuous purification device for abamectin Download PDF

Info

Publication number
CN213790075U
CN213790075U CN202022670916.1U CN202022670916U CN213790075U CN 213790075 U CN213790075 U CN 213790075U CN 202022670916 U CN202022670916 U CN 202022670916U CN 213790075 U CN213790075 U CN 213790075U
Authority
CN
China
Prior art keywords
abamectin
tower body
preparation tank
storage tank
tower
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202022670916.1U
Other languages
Chinese (zh)
Inventor
张丽强
王兴轩
杨飞
曲志西
高峰
张宾
龙燕
徐晓培
耿焕敏
甄江峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTH CHINA PHARMACEUTICAL GROUP AINO CO Ltd
Original Assignee
NORTH CHINA PHARMACEUTICAL GROUP AINO CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTH CHINA PHARMACEUTICAL GROUP AINO CO Ltd filed Critical NORTH CHINA PHARMACEUTICAL GROUP AINO CO Ltd
Priority to CN202022670916.1U priority Critical patent/CN213790075U/en
Application granted granted Critical
Publication of CN213790075U publication Critical patent/CN213790075U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The utility model relates to an abamectin continuous purification device, which comprises a washing liquid preparation tank, an abamectin preparation tank, an extraction tower, a waste liquid storage tank and a finished product storage tank, wherein the extraction tower comprises a tower body, a first feed inlet and a first discharge outlet which are arranged at the bottom of the tower body, and a second feed inlet and a second discharge outlet which are arranged at the top of the tower body, and feed distributors are respectively arranged at the first feed inlet and the second feed inlet; the first feed inlet is connected with the abamectin preparation tank, the second feed inlet is connected with the washing liquid preparation tank, the first discharge outlet is connected with the waste liquid storage tank, and the second discharge outlet is connected with the finished product storage tank. The equipment has the advantages of simple structure, convenient operation, stable yield and easy control of product quality. Can give consideration to both the purification effect and the equipment investment cost, and is suitable for large-scale application.

Description

Continuous purification device for abamectin
Technical Field
The utility model belongs to the technical field of chemical industry separation and purification equipment technique and specifically relates to an abamectin purifies device in succession.
Background
The existing preparation process of the abamectin fine powder mainly uses an organic solvent to dissolve abamectin, and then carries out cooling crystallization to obtain the abamectin fine powder, and the used equipment is a dissolving tank and a cooling crystallization tank. In the other preparation process, a column separation mode is mainly adopted to obtain the high-purity abamectin fine powder, equipment used in the process is mainly a preparative chromatography system, and the process has the advantage of good impurity removal effect, but has higher production cost and higher equipment investment, and is not suitable for large-scale production and application.
SUMMERY OF THE UTILITY MODEL
The utility model aims at providing an abamectin purifies device in succession to solve the unsatisfactory or big problem of equipment input cost of prior art edulcoration effect.
The utility model discloses a realize like this: a continuous abamectin purification device comprises a washing liquid preparation tank, an abamectin preparation tank, an extraction tower, a waste liquid storage tank and a finished product storage tank, wherein the extraction tower comprises a tower body, a first feeding hole and a first discharging hole which are formed in the bottom of the tower body, and a second feeding hole and a second discharging hole which are formed in the top of the tower body, and feeding distributors are arranged at the first feeding hole and the second feeding hole;
the first feed port is connected with the abamectin preparation tank, the second feed port is connected with the washing liquid preparation tank, the first discharge port is connected with the waste liquid storage tank, and the second discharge port is connected with the finished product storage tank;
the feeding distributor comprises a plurality of circles of annular pipes and a cross-shaped pipe which are concentrically arranged, the cross-shaped pipe is communicated with the annular pipes, and material distribution holes are uniformly distributed on the pipe walls of the annular pipes and the cross-shaped pipe.
The tower body is cylindric, the diameter of feeding distributor slightly is less than the diameter of tower body.
A packing layer is arranged in the tower body.
The thickness of the filler layer is not less than 1.5 m.
The filler layer is filled with stainless steel phi-shaped mesh filler, the diameter of the filler is 4mm, and the granularity is 80 meshes.
Diaphragm pumps are arranged between the first feed port and the abamectin preparation tank and between the second feed port and the washing liquid preparation tank.
Has the advantages that:
1. the device realizes continuous operation of the abamectin in the countercurrent extraction tower by continuously feeding the abamectin to the preparation tank, improves the treatment efficiency, and the traditional abamectin extraction and purification device is mainly a cooling crystallization tank and has an intermittent operation process.
2. The extraction process uses a counter-current extraction column designed according to the material properties. The heavier washing liquid enters the extraction tower through a feed inlet on the extraction tower and is uniformly dispersed by a feed distributor. The light abamectin solution enters through a feed inlet below the extraction tower and is uniformly dispersed through a feed distributor. A layer of stainless steel filler is paved in the middle of the extraction tower to increase the contact area. The abamectin dissolving solution and the washing liquid form convection in the tower due to the density difference, so that the impurity removal effect of the washing liquid on the abamectin dissolving solution is realized.
3. The equipment has the advantages of simple structure, convenient operation, stable yield and easy control of product quality. Can give consideration to both the purification effect and the equipment investment cost, and is suitable for large-scale application.
Drawings
Fig. 1 is a schematic structural diagram of the present invention.
Fig. 2 is a schematic structural diagram of the extraction tower of the present invention.
Fig. 3 is a schematic structural diagram of the feeding distributor of the present invention.
In the figure: 1. washing liquid preparation tank, 2, abamectin preparation tank, 3, extraction tower, 4, waste liquid storage tank, 5, finished product storage tank, 6, tower body, 7, first feed inlet, 8, first discharge outlet, 9, second feed inlet, 10, second discharge outlet, 11, feed distributor, 12, annular tube, 13, cross-shaped tube, 14, cloth hole, 15 and packing layer.
Detailed Description
As shown in fig. 1-3, the utility model discloses a structure includes that lotion prepares jar 1, abamectin prepares jar 2, extraction tower 3, waste liquid holding vessel 4 and finished product holding vessel 5, extraction tower 3 includes tower body 6, locate the first feed inlet 7 and the first discharge gate 8 of tower body bottom, locate second feed inlet 9 and the second discharge gate 10 at 6 tops of tower body, first feed inlet 7 links to each other with abamectin prepares jar 2, second feed inlet 9 links to each other with lotion prepares jar 1, first discharge gate 8 links to each other with waste liquid holding vessel 4, second discharge gate 10 links to each other with finished product holding vessel 5. Diaphragm pumps are arranged between the first feed port 7 and the abamectin preparation tank 2 and between the second feed port 9 and the washing liquid preparation tank 1.
The tower body 6 is cylindrical, and the first feed inlet 7 and the second feed inlet 9 are both provided with a feed distributor 11. The feeding distributor 11 comprises two circles of concentric annular pipes 12 and a cross-shaped pipe 13, the four tail ends of the cross-shaped pipe 13 are communicated with the outer annular pipe, the middle part of the cross-shaped pipe 13 is communicated with the inner annular pipe, and the center of the cross-shaped pipe 13 or the side wall of the annular pipe 12 is provided with an inlet connected with the feeding hole; the pipe walls of the annular pipe 12 and the cross-shaped pipe 13 are distributed with material distribution holes 14. The diameter of 11 of feeding distributor slightly is less than the diameter of tower body 6 to locate the upper and lower end of tower body 6, feeding distributor 11 is used for making the feed liquid evenly distributed that gets into, and flow into in the tower.
A packing layer 15 is arranged in the tower body 6, and the thickness of the packing layer 15 is not less than 1.5 m. The filler layer 15 is filled with stainless steel phi-shaped mesh filler, the diameter of the filler is 4mm, and the granularity is 80 meshes.
The device comprises the following steps when in use:
1) the abamectin is prepared into a solution with required concentration in an abamectin preparation tank. And preparing the washing liquor with the required concentration in the washing liquor preparation tank. Respectively inputting the abamectin solution and the washing liquid into a countercurrent extraction tower through a diaphragm pump. Two separate formulation tanks were used with a heating system. The feeding flow rate ratio of the washing liquid to the abamectin dissolving liquid is more than or equal to 1: 1.
2) The extraction tower is a columnar packed tower, the upper end and the lower end of the extraction tower are respectively provided with a feeding distributor with an annular pipe, a feeding hole is arranged in the middle of the upper seal head and the lower seal head of the tower body, and a discharging hole is arranged at the top end of the seal head. The dissolved solution and the washing liquid form convection in the extraction tower by utilizing the existing density difference, the washing liquid with higher density slowly moves downwards after being uniformly distributed by the distributor, and the abamectin dissolved solution with lower density slowly moves upwards after being uniformly distributed by the distributor, and is fully contacted in the stainless steel packing layer. After removing impurities by convection, the solution and the washing liquid are separated again. The extraction tower realizes the control of a split-phase interface by controlling the opening of a material inlet valve and a material outlet valve.
3) The dissolved solution enters a finished product storage tank through a second discharge port of the tower, and the washing solution enters a waste liquid storage tank through a first discharge port of the extraction tower.
4) And (4) concentrating and crystallizing the material in the finished product storage tank again to obtain the abamectin product.

Claims (6)

1. A continuous abamectin purification device is characterized by comprising a washing liquid preparation tank, an abamectin preparation tank, an extraction tower, a waste liquid storage tank and a finished product storage tank, wherein the extraction tower comprises a tower body, a first feeding hole and a first discharging hole which are formed in the bottom of the tower body, and a second feeding hole and a second discharging hole which are formed in the top of the tower body, and feeding distributors are arranged at the first feeding hole and the second feeding hole;
the first feed port is connected with the abamectin preparation tank, the second feed port is connected with the washing liquid preparation tank, the first discharge port is connected with the waste liquid storage tank, and the second discharge port is connected with the finished product storage tank;
the feeding distributor comprises a plurality of circles of annular pipes and a cross-shaped pipe which are concentrically arranged, the cross-shaped pipe is communicated with the annular pipes, and material distribution holes are uniformly distributed on the pipe walls of the annular pipes and the cross-shaped pipe.
2. The continuous abamectin purifying device according to claim 1, wherein the tower body is cylindrical, and the diameter of the feeding distributor is slightly smaller than that of the tower body.
3. The continuous abamectin purifying apparatus as set forth in claim 1, wherein a packing layer is set inside the tower.
4. The continuous abamectin purifying device according to claim 3, wherein the thickness of the packing layer is not less than 1.5 m.
5. The continuous abamectin purifying device according to claim 3, wherein the filler layer is filled with stainless steel phi-shaped mesh filler, the diameter of the filler is 4mm, and the granularity is 80 meshes.
6. The abamectin continuous purification device according to claim 1, wherein diaphragm pumps are arranged between the first feeding hole and the abamectin preparation tank and between the second feeding hole and the washing liquid preparation tank.
CN202022670916.1U 2020-11-18 2020-11-18 Continuous purification device for abamectin Active CN213790075U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202022670916.1U CN213790075U (en) 2020-11-18 2020-11-18 Continuous purification device for abamectin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202022670916.1U CN213790075U (en) 2020-11-18 2020-11-18 Continuous purification device for abamectin

Publications (1)

Publication Number Publication Date
CN213790075U true CN213790075U (en) 2021-07-27

Family

ID=76935304

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202022670916.1U Active CN213790075U (en) 2020-11-18 2020-11-18 Continuous purification device for abamectin

Country Status (1)

Country Link
CN (1) CN213790075U (en)

Similar Documents

Publication Publication Date Title
CN105175208B (en) Acetylene hydrogenation prepares the method for ethene and the reaction tower for this method
CN108862332B (en) Carbonation crystallization device and use thereof and preparation method of sodium bicarbonate
CN203999113U (en) A kind of pulse aerating apparatus and comprise the MBR film system of this device
CN106669867A (en) Continuous and automatic ion exchange device
CN213790075U (en) Continuous purification device for abamectin
CN203315784U (en) Scraper crystallization separator
RU2505524C2 (en) Reactor of paraxylol oxidation for obtaining terephthalic acid
CN203612952U (en) Extraction device for hydrogen peroxide production with anthraquinone process
CN102583257A (en) Extraction equipment and method for preparing oxyful via anthraquinone process
CN205253071U (en) Air -lift type circular current reactor
CN108862205B (en) Hydrogen peroxide preparation device
CN204981232U (en) System for resin adsorbs handles waste water
CN201684460U (en) Precision filter
CN220176118U (en) Purifying device for fluidized bed hydrogen peroxide production product
CN205730810U (en) A kind of hexamethylenamine formaldehyde air purifying apparatus
CN1136146C (en) Integrated equipment and process for hydrogen antiraquinone oxidation and H2O2 extraction in producing H2O2
CN215234235U (en) Carbon three hydrogenation reaction container
CN207581696U (en) Continuity method isomerization produces the device of durol
CN106892408A (en) A kind of method for oxidation of hydrogen peroxide production process
CN212770518U (en) Continuous hydrolysis and separation device for pivalic acid carbonyl material
CN210826201U (en) Starch sugar decoloration device
CN213912422U (en) Forced film-distribution melting crystallizer
CN212631790U (en) Rectifying column distributor
CN201076810Y (en) Hollow fiber film assembly
CN202226826U (en) Continuous hydrogenation production system device

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Zhang Liqiang

Inventor after: Geng Huanmin

Inventor after: Zhen Jiangfeng

Inventor after: Lu Kaixiao

Inventor after: Wang Kehua

Inventor after: Wang Xingxuan

Inventor after: Yang Fei

Inventor after: Qu Zhixi

Inventor after: Gao Feng

Inventor after: Zhang Bin

Inventor after: Long Yan

Inventor after: Xu Xiaopei

Inventor before: Zhang Liqiang

Inventor before: Zhen Jiangfeng

Inventor before: Wang Xingxuan

Inventor before: Yang Fei

Inventor before: Qu Zhixi

Inventor before: Gao Feng

Inventor before: Zhang Bin

Inventor before: Long Yan

Inventor before: Xu Xiaopei

Inventor before: Geng Huanmin

CB03 Change of inventor or designer information